211 related articles for article (PubMed ID: 27914953)
1. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.
Atasoy İL; Dursun E; Gezen-Ak D; Metin-Armağan D; Öztürk M; Yılmazer S
J Chem Neuroanat; 2017 Mar; 80():19-26. PubMed ID: 27914953
[TBL] [Abstract][Full Text] [Related]
2. Okadaic acid-induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons.
Metin-Armağan D; Gezen-Ak D; Dursun E; Atasoy İL; Karabay A; Yılmazer S; Öztürk M
J Chem Neuroanat; 2018 Oct; 92():41-47. PubMed ID: 29860071
[TBL] [Abstract][Full Text] [Related]
3. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
[TBL] [Abstract][Full Text] [Related]
4. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
5. Induction of Bcl-2 and Bax was related to hyperphosphorylation of tau and neuronal death induced by okadaic acid in rat brain.
Chen LQ; Wei JS; Lei ZN; Zhang LM; Liu Y; Sun FY
Anat Rec A Discov Mol Cell Evol Biol; 2005 Dec; 287(2):1236-45. PubMed ID: 16265626
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons.
Kwon KJ; Lee EJ; Cho KS; Cho DH; Shin CY; Han SH
Food Funct; 2015 Jun; 6(6):2058-67. PubMed ID: 26032477
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine directly increases tau phosphorylation.
Huang C; Ho YS; Ng OT; Irwin MG; Chang RC; Wong GT
J Alzheimers Dis; 2015; 44(3):839-50. PubMed ID: 25374108
[TBL] [Abstract][Full Text] [Related]
9. Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment.
Kim D; Su J; Cotman CW
Brain Res; 1999 Aug; 839(2):253-62. PubMed ID: 10519048
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation.
Broetto N; Hansen F; Brolese G; Batassini C; Lirio F; Galland F; Dos Santos JP; Dutra MF; Gonçalves CA
Brain Res Bull; 2016 Jun; 124():136-43. PubMed ID: 27108544
[TBL] [Abstract][Full Text] [Related]
11. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation.
Ho DT; Shayan H; Murphy TH
J Neurochem; 1997 Jan; 68(1):106-11. PubMed ID: 8978715
[TBL] [Abstract][Full Text] [Related]
12. The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro.
Chen Q; Zhou Z; Zhang L; Xu S; Chen C; Yu Z
PLoS One; 2014; 9(3):e91793. PubMed ID: 24618580
[TBL] [Abstract][Full Text] [Related]
13. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
[TBL] [Abstract][Full Text] [Related]
14. Tau hyperphosphorylation affects Smad 2/3 translocation.
Baig S; van Helmond Z; Love S
Neuroscience; 2009 Oct; 163(2):561-70. PubMed ID: 19555739
[TBL] [Abstract][Full Text] [Related]
15. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
[TBL] [Abstract][Full Text] [Related]
16. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease.
Alvarez-de-la-Rosa M; Silva I; Nilsen J; Pérez MM; García-Segura LM; Avila J; Naftolin F
Ann N Y Acad Sci; 2005 Jun; 1052():210-24. PubMed ID: 16024764
[TBL] [Abstract][Full Text] [Related]
17. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
18. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.
Rametti A; Esclaire F; Yardin C; Terro F
J Biol Chem; 2004 Dec; 279(52):54518-28. PubMed ID: 15475565
[TBL] [Abstract][Full Text] [Related]
19. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.
Zhang Z; Simpkins JW
Brain Res; 2010 Jul; 1345():176-81. PubMed ID: 20457142
[TBL] [Abstract][Full Text] [Related]
20. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
